4F9B D 1,14,3.5,0.0318,1.1,0.0,Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
3L4W A 1,12,3.5,0.0351,1.2,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Miglitolÿ
3L4T A 1,12,3.5,0.0359,1.2,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Bj2661ÿ
3LPP A 1,12,3.5,0.0340,1.2,0.0,Crystal Complex Of N-Terminal Sucrase-Isomaltase With Kotalanolÿ
3LPO B 1,12,3.5,0.0318,1.2,0.0,Crystal Structure Of The N-Terminal Domain Of Sucrase- Isomaltaseÿ
3LPO D 1,12,3.5,0.0318,1.2,0.0,Crystal Structure Of The N-Terminal Domain Of Sucrase- Isomaltaseÿ
3LPO C 1,12,3.5,0.0318,1.2,0.0,Crystal Structure Of The N-Terminal Domain Of Sucrase- Isomaltaseÿ
3LPO A 1,12,3.5,0.0318,1.2,0.0,Crystal Structure Of The N-Terminal Domain Of Sucrase- Isomaltaseÿ
3LPP B 1,12,3.5,0.0318,1.2,0.0,Crystal Complex Of N-Terminal Sucrase-Isomaltase With Kotalanolÿ
3L4X A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Nr4-8ÿ
1PSP B 2,12,3.5,0.0489,1.3,0.0,Pancreatic Spasmolytic Polypeptide (Psp)
3L4Z A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Salacinolÿ
3L4Y A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Nr4-8iiÿ
3L4U A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With De-O-Sulfonated Kotalanolÿ
3LPP C 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Sucrase-Isomaltase With Kotalanolÿ
2QMJ A 1,12,3.5,0.0318,1.3,0.0,Crystral Structure Of The N-Terminal Subunit Of Human Maltase-Glucoamylase In Complex With Acarbose
2QLY A 1,12,3.5,0.0318,1.3,0.0,Crystral Structure Of The N-Terminal Subunit Of Human Maltase-Glucoamylase
3L4V A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Kotalanolÿ
3CTT A 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Human Maltase-Glucoamylase With Casuarineÿ
2PO0 A 2,24,6.5,0.0023,1.3,0.0,Crystal Structure Of The P. Abyssi Exosome Rnase Ph Ring Complexed With Adp In Double Conformation
1POS B 1,12,3.5,0.0318,1.3,0.0,Porcine Pancreatic Spasmolytic Polypeptide
2PSP B 1,12,3.5,0.0318,1.3,0.0,Porcine Pancreatic Spasmolytic Polypeptide
3LPP D 1,12,3.5,0.0318,1.3,0.0,Crystal Complex Of N-Terminal Sucrase-Isomaltase With Kotalanolÿ
3TOP A 1,12,3.5,0.0468,1.4,0.0,Crystral Structure Of The C-Terminal Subunit Of Human Maltase- Glucoamylase In Complex With Acarboseÿ
3TOP B 1,12,3.5,0.0429,1.4,0.0,Crystral Structure Of The C-Terminal Subunit Of Human Maltase- Glucoamylase In Complex With Acarboseÿ
3JR7 A 2,26,5.2,0.0228,1.4,7.7,The Crystal Structure Of The Protein Of Degv Family Cog1307 With Unknown Function From Ruminococcus Gnavus Atcc 29149ÿ
1PSP B 1,12,3.5,0.0318,1.5,0.0,Pancreatic Spasmolytic Polypeptide (Psp)
2OSG A ,16,5.2,0.0105,1.5,18.8,Solution Structure And Binding Property Of The Domain- Swapped Dimer Of Zo2pdz2
2OSG B ,16,5.2,0.0105,1.5,18.8,Solution Structure And Binding Property Of The Domain- Swapped Dimer Of Zo2pdz2
1PSP A 1,12,3.5,0.0318,1.6,0.0,Pancreatic Spasmolytic Polypeptide (Psp)
1POS A 1,12,3.5,0.0318,1.6,0.0,Porcine Pancreatic Spasmolytic Polypeptide
3KRN A 2,22,6.3,0.0076,1.7,4.5,Crystal Structure Of C. Elegans Cell-Death-Related Nuclease 5(Crn-5)ÿ
4BAH B 1,39,8.2,0.0078,1.7,7.7,Thrombin In Complex With Inhibitor
1SGF Z 1,42,8.3,0.0004,1.7,4.8,Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth Factor With Four Binding Proteins (Serine Proteinases)
2PV9 B 2,41,8.3,0.0057,1.7,12.2,Crystal Structure Of Murine Thrombin In Complex With The Extracellular Fragment Of Murine Par4
3UTU H 2,39,8.3,0.0298,1.7,7.7,High Affinity Inhibitor Of Human Thrombin
4BAM B 2,39,8.4,0.0033,1.7,7.7,Thrombin In Complex With Inhibitor
3DSR A 1,32,6.4,0.0472,1.7,18.8,Adp In Transition Binding Site In The Subunit B Of The Energy Converter A1ao Atp Synthaseÿ
1HXE H 2,39,8.5,0.0130,1.7,7.7,Serine Protease
1A5H A 2,44,8.0,0.0015,1.7,11.4,Catalytic Domain Of Human Two-Chain Tissue Plasminogen Activator Complex Of A Bis-Benzamidine
1A5H B 2,44,8.0,0.0016,1.7,11.4,Catalytic Domain Of Human Two-Chain Tissue Plasminogen Activator Complex Of A Bis-Benzamidine
1DM4 B 1,40,8.4,0.0180,1.7,7.5,Ser195ala Mutant Of Human Thrombin Complexed With Fibrinopeptide A (7-16)ÿ
1DIT H 2,40,8.5,0.0026,1.7,7.5,Complex Of A Divalent Inhibitor With Thrombin
3SV2 H 2,40,8.3,0.0055,1.7,7.5,Human Thrombin In Complex With Ubthr105
2ZDV H 2,40,8.3,0.0305,1.7,7.5,Exploring Thrombin S1 Pocket
2HGT H 2,40,8.3,0.0043,1.7,7.5,Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha- Thrombinÿ
1YPE H 2,40,8.4,0.0198,1.7,7.5,Thrombin Inhibitor Complex
2ZO3 H 2,40,8.3,0.0335,1.7,7.5,Bisphenylic Thrombin Inhibitorsÿ
3RM2 H 2,40,8.3,0.0305,1.7,7.5,Human Thrombin In Complex With Mi003ÿ
1AIX H 1,40,8.4,0.0177,1.7,7.5,Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Boroval
2ZIQ H 2,40,8.3,0.0334,1.7,7.5,Thrombin Inhibitionÿ
3F68 H 2,40,8.3,0.0050,1.7,7.5,Thrombin Inhibitionÿ
1TMB H 2,39,8.5,0.0130,1.7,7.7,Molecular Basis For The Inhibition Of Human Alpha-Thrombin By The Macrocyclic Peptide Cyclotheonamide A
1D3D B 2,40,8.5,0.0158,1.7,7.5,Crystal Structure Of Human Alpha Thrombin In Complex With Benzothiophene Inhibitor 4
1RIW B ,40,8.2,0.0086,1.7,7.5,Thrombin In Complex With Natural Product Inhibitor Oscillarin
3OBY A 1,41,7.4,0.0303,1.8,2.4,Crystal Structure Of Archaeoglobus Fulgidus Pelota Reveals Inter- Domain Structural Plasticityÿ
2NN6 C 2,30,6.2,0.0097,1.8,10.0,Structure Of The Human Rna Exosome Composed Of Rrp41, Rrp45, Rrp46, Rrp43, Mtr3, Rrp42, Csl4, Rrp4, And Rrp40
3DUX H 2,40,8.4,0.0238,1.8,7.5,Understanding Thrombin Inhibitionÿ
1D3Q B 1,40,8.4,0.0182,1.8,7.5,Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 2
1B5G H 2,40,8.4,0.0182,1.8,7.5,Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen
1A61 H 2,40,8.4,0.0195,1.8,7.5,Thrombin Complexed With A Beta-Mimetic Thiazole-Containing Inhibitor
1H8D H 2,40,8.1,0.0119,1.8,7.5,X-Ray Structure Of The Human Alpha-Thrombin Complex With A Tripeptide Phosphonate Inhibitor
1ABJ H 2,40,8.3,0.0063,1.8,7.5,Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S' Subsites Of Substrates And Inhibitors
3EIU B 1,39,6.5,0.0307,1.8,12.8,A Second Transient Position Of Atp On Its Trail To The Nucleotide-Binding Site Of Subunit B Of The Motor Protein A1ao Atp Synthaseя
4RQZ A 2,24,6.3,0.0051,1.8,4.2,Re-refinement Of 1soz, Crystal Structure Of Degs Protease In Complex With An Activating Peptide
7GCH F ,40,7.1,0.0108,1.8,7.5,Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor Complexes. Comparison Of Slowly And Rapidly Equilibrating Inhibitors
1A5I A 2,45,8.2,0.0082,1.8,13.3,Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva Plasminogen Activator In Complex With Egr-Cmk (Glu-Gly-Arg Chloromethyl Ketone)
1BDA A 2,44,8.1,0.0011,1.8,11.4,Catalytic Domain Of Human Single Chain Tissue Plasminogen Activator In Complex With Dansyl-Egr-Cmk (Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
2RKW B 1,29,6.1,0.0180,1.8,13.8,Intermediate Position Of Atp On Its Trail To The Binding Pocket Inside The Subunit B Mutant R416w Of The Energy Converter A1ao Atp Synthase
1TBR K 1,39,8.0,0.0162,1.8,10.3,Crystal Structure Of Insect Derived Double Domain Kazal Inhibitor Rhodniin In Complex With Thrombin
2PSY A 1,39,8.0,0.0183,1.8,10.3,Crystal Structure Of Human Kallikrein 5 In Complex With Leupeptin And Zincя
2PSX A 1,39,8.2,0.0007,1.8,10.3,Crystal Structure Of Human Kallikrein 5 In Complex With Leupeptin
1O5E H 2,42,8.0,0.0075,1.8,7.1,Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
4RR0 A 2,24,6.1,0.0132,1.8,4.2,Re-refined 1vcw, Crystal Structure Of Degs After Backsoaking The Activating Peptide
3P70 B 1,42,8.5,0.0162,1.8,7.1,Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junctionя
2XWA A 2,41,8.1,0.0012,1.8,4.9,Crystal Structure Of Complement Factor D Mutant R202aя
1TFP B 2,31,5.2,0.0308,1.8,3.2,Transthyretin (Formerly Known As Prealbumin)
4E05 H 2,42,8.4,0.0038,1.8,7.1,Anophelin From The Malaria Vector Inhibits Thrombin Through A Novel Reverse-Binding Mechanism
1DOJ A 2,44,8.5,0.0146,1.8,9.1,Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex At 1.7 A
1LHF H 2,42,8.6,0.0017,1.8,9.5,Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-Homolys-Oh
2A0Q B 2,44,8.3,0.0251,1.8,9.1,Structure Of Thrombin In 400 Mm Potassium Chloride
3P70 H 1,42,8.5,0.0156,1.8,7.1,Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junctionя
3QGN B 2,45,8.6,0.0102,1.9,8.9,The Allosteric E-E Equilibrium Is A Key Property Of The Trypsin Foldя
3HKM A 2,28,6.3,0.0067,1.9,0.0,Crystal Structure Of Rice(Oryza Sativa) Rrp46я
4H6S B 2,44,8.2,0.0066,1.9,9.1,Crystal Structure Of Thrombin Mutant E14ea/d14la/e18a/s195a
2NWN A 2,45,7.5,0.0307,1.9,4.4,New Pharmacophore For Serine Protease Inhibition Revealed By Crystal Structure Of Human Urokinase-Type Plasminogen Activator Complexed With A Cyclic Peptidyl Inhibitor, Upain-1
1NU7 F 2,42,8.2,0.0374,1.9,7.1,Staphylocoagulase-Thrombin Complex
4E06 H 2,42,8.2,0.0352,1.9,7.1,Anophelin From The Malaria Vector Inhibits Thrombin Through A Novel Reverse-Binding Mechanism
3MCA B 1,37,6.9,0.0270,1.9,5.4,Structure Of The Dom34-Hbs1 Complex And Implications For Its Role In No-Go Decayя
1IHS H 2,42,8.2,0.0445,1.9,9.5,Crystal Structure Of The Complex Of Human Alpha-Thrombin And Non-Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6я
1ZHP A 2,45,7.7,0.0053,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With Benzamidine (S434a-T475a-K505 Mutant)я
3P6Z B 2,44,8.3,0.0262,1.9,9.1,Structural Basis Of Thrombin Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junctionя
6CHA B ,41,8.1,0.0119,1.9,7.3,Structure Of A Tetrahedral Transition State Complex Of Alpha-Chymotrypsin At 1.8-Angstroms Resolution
3R5P A ,49,9.1,10e-4.0,1.9,10.2,Structure Of Ddn, The Deazaflavin-Dependent Nitroreductase From Mycobacterium Tuberculosis Involved In Bioreductive Activation Of Pa- 824я
2B5T B 2,44,8.1,0.0122,1.9,9.1,2.1 Angstrom Structure Of A Nonproductive Complex Between Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two S195a Thrombin Molecules
3OBY B 1,44,7.5,0.0210,1.9,2.3,Crystal Structure Of Archaeoglobus Fulgidus Pelota Reveals Inter- Domain Structural Plasticityя
1WAY B 2,42,8.2,0.0403,1.9,7.1,Active Site Thrombin Inhibitors
2ZEC D 2,41,6.7,0.0460,1.9,12.2,Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
3SQH E 2,44,8.6,0.0112,1.9,9.1,Crystal Structure Of Prethrombin-2 Mutant S195a In The The Open Formя
3R3G B 2,44,8.7,0.0056,1.9,9.1,Structure Of Human Thrombin With Residues 145-150 Of Murine Thrombinя
4MLF B 2,41,8.3,0.0307,1.9,7.3,Crystal Structure For The Complex Of Thrombin Mutant D102n And Hirudin
3P6Z H 2,44,8.4,0.0234,1.9,9.1,Structural Basis Of Thrombin Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junctionя
3C1K A 2,42,8.3,0.0054,1.9,9.5,Crystal Structure Of Thrombin In Complex With Inhibitor 15
4LOY H 2,42,8.2,0.0404,1.9,7.1,Crystal Structure Analysis Of Thrombin In Complex With Compound D57, 5-chlorothiophene-2-carboxylic Acid [(s)-2-[2-methyl-3-(2- Oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1- Yl)- 3-oxopropyl]amide (sar107375)
3NUM A 1,41,7.0,0.0129,1.9,9.8,Substrate Induced Remodeling Of The Active Site Regulates Htra1 Activityя
2GP9 B 2,44,8.4,0.0036,1.9,9.1,Crystal Structure Of The Slow Form Of Thrombin In A Self- Inhibited Conformation
7KME H 2,41,8.5,0.0027,1.9,7.3,Crystal Structure Of Human Alpha-Thrombin Inhibited With Sel2711
4Y8Y A 2,45,7.7,0.0011,1.9,13.3,Factor Xia In Complex With The Inhibitor Methyl (4-{4-chloro-2-[(1s)- 1-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)- 3-(morpholin-4-yl)-3-oxopropyl]-1h-imidazol-5-yl}phenyl)carbamate
1LHD H 2,44,8.2,0.0083,1.9,9.1,Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Borolys-Oh
1DWB H 2,41,8.3,0.0046,1.9,7.3,Alpha-Thrombin (E.C.3.4.21.5) Complex With (Des-Amino Asp 55) Hirudin (Residues 55 - 65) And Benzamidine
3VXE H 2,42,8.2,0.0087,1.9,9.5,Human Alpha-thrombin-bivalirudin Complex At Pd5.0
5CHA F ,42,8.2,0.0008,1.9,7.1,The Refinement And The Structure Of The Dimer Of Alpha- Chymotrypsin At 1.67-Angstroms Resolution
4CHA B ,42,7.8,0.0036,1.9,7.1,Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms Resolution
3S7H B 2,44,8.2,0.0073,1.9,9.1,Structure Of Thrombin Mutant Y225p In The E Formя
1GJ5 H 2,42,8.5,0.0130,1.9,9.5,Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190ALA190 PROTEASE, STRUCTURE-Based Drug Design
1TB6 H 2,44,8.0,0.0186,1.9,9.1,2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex
3GIC B 2,44,8.3,0.0059,1.9,9.1,Structure Of Thrombin Mutant Delta(146-149e) In The Free Formя
1AWF H 1,43,8.2,0.0440,1.9,9.3,Novel Covalent Thrombin Inhibitor From Plant Extract
3DA9 B 2,41,8.2,0.0482,1.9,7.3,Crystal Structure Of Thrombin In Complex With Inhibitorя
1A2C H 1,43,8.3,0.0054,1.9,9.3,Structure Of Thrombin Inhibited By Aeruginosin298-A From A Blue-Green Alga
2OCV B 2,44,8.1,0.0130,1.9,13.6,Structural Basis Of Na+ Activation Mimicry In Murine Thrombin
1CA0 B ,42,7.8,0.0315,1.9,7.1,Bovine Chymotrypsin Complexed To Appi
3P70 D 2,44,8.5,0.0024,1.9,9.1,Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junctionÿ
4CRD A 2,45,7.6,0.0017,1.9,13.3,Creating Novel F1 Inhibitors Through Fragment Based Lead Generation And Structure Aided Drug Design
2PGB B 1,42,8.5,0.0136,1.9,7.1,Inhibitor-Free Human Thrombin Mutant C191a-C220a
1BHX B ,43,8.6,0.0111,1.9,9.3,X-Ray Structure Of The Complex Of Human Alpha Thrombin With The Inhibitor Sdz 229-357
3HKM B 1,28,6.4,0.0320,1.9,0.0,Crystal Structure Of Rice(Oryza Sativa) Rrp46ÿ
3P17 H 2,42,8.5,0.0158,1.9,9.5,Thrombin Inhibition By Pyridin Derivativesÿ
1YCP K 1,42,8.4,0.0208,1.9,11.9,The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y) Bound To Bovine Thrombin Explains Why The Mutation Of Phe- 8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16ÿ
8KME 2 2,43,8.4,0.0031,1.9,9.3,Crystal Structure Of Human Alpha-thrombin Inhibited With Sel2770
2JH5 D 1,43,8.4,0.0189,1.9,9.3,Human Thrombin Hirugen Inhibitor Complex
1C4V 2 2,43,8.2,0.0080,1.9,9.3,Selective Non Electrophilic Thrombin Inhibitors With Cyclohexyl Moieties.
3U9A H 2,43,8.4,0.0175,1.9,9.3,Human Thrombin In Complex With Mi330
3SI4 H 2,42,8.4,0.0038,1.9,9.5,Human Thrombin In Complex With Ubthr104
3QTO H 2,43,8.4,0.0028,1.9,9.3,Thrombin Inhibition By Pyridin Derivativesÿ
2PGQ B 2,44,8.3,0.0275,1.9,9.1,Human Thrombin Mutant C191a-C220a In Complex With The Inhibitor Ppack
1TA2 A 2,43,8.4,0.0234,1.9,9.3,Crystal Structure Of Thrombin In Complex With Compound 1
4RQZ C 2,20,6.2,0.0095,1.9,5.0,Re-refinement Of 1soz, Crystal Structure Of Degs Protease In Complex With An Activating Peptide
5EIY A 3,55,7.4,0.0444,1.9,12.7,Bacterial Cellulose Synthase Bound To A Substrate Analogue
3QX5 H 2,42,8.3,0.0043,1.9,9.5,Thrombin Inhibition By Pyridin Derivativesÿ
1D6W A 2,42,8.5,0.0118,1.9,9.5,Structure Of Thrombin Complexed With Selective Non- Electrophilic Inhibitors Having Cyclohexyl Moieties At P1
3SHA H 2,43,8.5,0.0025,1.9,9.3,Human Thrombin In Complex With Ubthr97
3RMN H 2,43,8.4,0.0196,1.9,9.3,Human Thrombin In Complex With Mi341ÿ
1RD3 D 2,44,8.1,0.0111,1.9,9.1,2.5a Structure Of Anticoagulant Thrombin Variant E217k
3S7K B 2,44,8.2,0.0362,1.9,9.1,Structure Of Thrombin Mutant Y225p In The E Formÿ
1B7X B 2,45,8.3,0.0314,1.9,8.9,Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D- Phe-Pro-Arg-Chloromethylketone
1BBR K 2,44,8.4,0.0209,1.9,11.4,The Structure Of Residues 7-16 Of The A Alpha Chain Of Human Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms Resolutionÿ
2JH6 D 1,43,8.4,0.0217,1.9,9.3,Human Thrombin Hirugen Inhibitor Complex
1HLT K 1,41,8.2,0.0090,1.9,7.3,The Structure Of A Nonadecapeptide Of The Fifth Egf Domain Of Thrombomodulin Complexed With Thrombin
1ZMN A 2,45,6.8,0.0406,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3, 2-Dioxaborolan-2-Yl)phenyl)guanidine
1QUR H 2,42,8.3,0.0251,1.9,7.1,Human Alpha-Thrombin In Complex With Bivalent, Benzamidine-Based Synthetic Inhibitor
2AFQ B 2,44,8.3,0.0348,1.9,9.1,1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin In The Sodium Free Stateÿ
1ZTL A 2,45,7.5,0.0101,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2- Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
4HTC H 2,41,8.3,0.0045,1.9,9.8,Alpha-Thrombin (E.C.3.4.21.5) Complex With Recombinant Hirudin (Variant 2, Lys 47)
1IHT H 2,42,8.2,0.0437,1.9,7.1,Crystal Structure Of The Complex Of Human Alpha-Thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6
1ZSJ A 2,45,6.8,0.0366,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With N-(7-Carbamimidoyl-Naphthalen-1- Yl)-3-Hydroxy-2-Methyl-Benzamide
3RLW H 2,43,8.4,0.0032,1.9,9.3,Human Thrombin In Complex With Mi328ÿ
1JOU B 2,44,8.2,0.0080,1.9,9.1,Crystal Structure Of Native S195a Thrombin With An Unoccupied Active Site
1TQ7 B 2,44,8.1,0.0135,1.9,9.1,Crystal Structure Of The Anticoagulant Thrombin Mutant W215aE217A Bound To Ppack
1QBV H 1,43,8.2,0.0481,1.9,9.3,Crystal Structure Of Thrombin Complexed With An Guanidine- Mimetic Inhibitor
3CR8 A 1,33,7.1,0.0144,1.9,15.2,Hexameric Aps Kinase From Thiobacillus Denitrificansÿ
1BHX B 1,44,8.6,0.0111,1.9,9.1,X-Ray Structure Of The Complex Of Human Alpha Thrombin With The Inhibitor Sdz 229-357
1KTS B 2,42,8.5,0.0114,1.9,9.5,Thrombin Inhibitor Complex
4HG6 A 4,58,8.2,0.0029,1.9,12.1,Structure Of A Cellulose Synthase - Cellulose Translocation Intermediate
1ZTK A 2,45,7.7,0.0053,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h- Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)- Butyl]-Acetamide
3BV9 B 2,44,8.3,0.0061,1.9,9.1,Structure Of Thrombin Bound To The Inhibitor Fm19ÿ
2ZHQ H 2,43,8.4,0.0222,1.9,9.3,Thrombin Inhibitionÿ
1A3B H 2,43,8.2,0.0359,1.9,9.3,Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog1
1G37 A 2,43,8.3,0.0336,1.9,9.3,Crystal Structure Of Human Alpha-Thrombin Complexed With Bch-10556 And Exosite-Directed Peptide
4Q7X A 2,42,8.3,0.0052,1.9,7.1,Neutrophil Serine Protease 4 (prss57) Apo Form 1
4Q7X B 2,42,8.3,0.0052,1.9,7.1,Neutrophil Serine Protease 4 (prss57) Apo Form 1
1TBZ H 2,43,8.4,0.0210,1.9,9.3,Human Thrombin With Active Site N-Methyl-D Phenylalanyl-N-[5- (Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen
1DWC H 2,43,8.3,0.0321,1.9,9.3,Alpha-Thrombin (E.C.3.4.21.5) Complex With (Des-Amino Asp 55) Hirudin (Residues 55 - 65) And Md-805 (Argatroban)
3RLY H 2,43,8.4,0.0209,1.9,9.3,Human Thrombin In Complex With Mi329ÿ
2EI8 A 2,40,7.6,0.0073,1.9,7.5,Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5- Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2- [(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
4OO1 B 2,30,6.3,0.0072,1.9,3.3,Structure Of The Exosome Component In Complex With Rna
3BEF E 2,40,8.3,0.0051,1.9,10.0,Crystal Structure Of Thrombin Bound To The Extracellular Fragment Of Par1
1MUE B 2,43,8.5,0.0139,1.9,9.3,Thrombin-Hirugen-L405,426
1DWD H 2,43,8.3,0.0324,1.9,9.3,Alpha-Thrombin (E.C.3.4.21.5) Complex With (Des-Amino Asp 55) Hirudin (Residues 55 - 65) And Napap
1ZSK A 2,45,6.8,0.0419,1.9,13.3,Crystal Structure Of The Catalytic Domain Of Coagulation Factor Xi In Complex With 6-Carbamimidoyl-4-(3-Hydroxy-2- Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid Methyl Ester
